Bridgeway Capital Management’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $24.5K | Sell |
|
|||||
|
2022
Q3 | $149K | Hold |
|
|||||
|
2022
Q2 | $53K | Sell |
|
|||||
|
2022
Q1 | $107K | Sell |
|
|||||
|
2021
Q4 | $143K | Sell |
|
|||||
|
2021
Q3 | $329K | Buy |
|
|||||
|
2021
Q2 | $207K | Sell |
|
|||||
|
2021
Q1 | $683K | Sell |
|
|||||
|
2020
Q4 | $560K | Buy |
|
|||||
|
2020
Q3 | $478K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $531K | Hold |
|
|||||
|
2019
Q3 | $579K | Buy |
|
|||||
|
2019
Q2 | $419K | Hold |
|
|||||
|
2019
Q1 | $586K | Hold |
|
|||||
|
2018
Q4 | $502K | Sell |
|
|||||
|
2018
Q3 | $1.2M | Sell |
|
|||||
|
2018
Q2 | $1.2M | Hold |
|
|||||
|
2018
Q1 | $908K | Buy |
|
|||||
|
2017
Q4 | $853K | Hold |
|
|||||
|
2017
Q3 | $1.07M | Hold |
|
|||||
|
2017
Q2 | $1.25M | Buy |
|
|||||
|
2017
Q1 | $648K | Hold |
|
|||||
|
2016
Q4 | $940K | Sell |
|
|||||
|
2016
Q3 | $1.86M | Sell |
|
|||||
|
2016
Q2 | $1.74M | Buy |
|
|||||
|
2016
Q1 | $559K | Buy |
|
|||||
|
2015
Q4 | $432K | Buy |
|
|||||
|
2015
Q3 | $200K | Buy |
|
|||||
|
2015
Q2 | $116K | Buy |
|